3//SEC Filing
STONEPINE CAPITAL, L.P. 3
Accession 0001567619-19-019138
CIK 0000827809other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:13 PM ET
Size
5.4 KB
Accession
0001567619-19-019138
Insider Transaction Report
Form 3
STONEPINE CAPITAL, L.P.
10% Owner
Holdings
- 3,703,420
Common Stock
Footnotes (2)
- [F1]The filers (the "Filers") are Stonepine Capital, L.P. (the "Partnership"), Stonepine Capital Management, LLC (the "General Partner"), Jon M. Plexico and Timothy P. Lynch. The General Partner is the general partner and investment adviser of the Partnership. Mr. Plexico and Mr. Lynch are the General Partner's managers and control persons. These securities are held directly by the Partnership for the benefit of its investors and are indirectly beneficially owned by the General Partner and Mr. Plexico and Mr. Lynch as the General Partner's control persons. The Partnership is filing this Form 3 for itself and the other Filers.
- [F2]The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each Filer disclaims beneficial ownership of these securities except to the extent of that Filer's pecuniary interest therein.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001370042
Filing Metadata
- Form type
- 3
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:13 PM ET
- Size
- 5.4 KB